K. Oh

The prognostic role of soluble transforming growth factor‐β and its correlation with soluble programmed death‐ligand 1 in biliary tract cancer

Ji‐Won Kim, J. W. Kim, D. Oh, 2020, Liver international : official journal of the International Association for the Study of the Liver.

A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers

D. Oh, Ah-Rong Nam, Ju-hee Bang, 2021, Oncogene.

Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.

M. Rebelatto, J. W. Kim, P. Mccoon, 2022, The lancet. Gastroenterology & hepatology.

Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer

D. Oh, Ah-Rong Nam, Ju-hee Bang, 2021, Cancer research and treatment.

WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers

D. Oh, Ah-Rong Nam, M. Jin, 2021, Gastric Cancer.

Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients

D. Oh, Ah-Rong Nam, M. Jin, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Prognostic value of serum soluble programmed death-ligand 1 (sPDL1) and dynamics during chemotherapy in advanced gastric cancer patients.

Y. Bang, J. E. Park, D. Oh, 2019, Journal of Clinical Oncology.

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer

Y. Bang, D. Oh, Ah-Rong Nam, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer.

D. Oh, Ah-Rong Nam, M. Jin, 2021, Cancer letters.